GLP-1 RAS FOR TREATING METABOLIC DYSFUNCTION-ASSOCIATED STEATOSIS LIVER DISEASE FROM GLP-1 DISCOVERY TO FDA APPROVAL: A COMPREHENSIVE NARRATIVE REVIEW